Patrick James Orme

Array ( [id] => 6817682 [patent_doc_number] => 20030068640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders' [patent_app_type] => new [patent_app_number] => 10/244633 [patent_app_country] => US [patent_app_date] => 2002-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 29543 [patent_no_of_claims] => 111 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20030068640.pdf [firstpage_image] =>[orig_patent_app_number] => 10244633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6831614 [patent_doc_number] => 20030182672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Genetic silencing' [patent_app_type] => new [patent_app_number] => 10/245805 [patent_app_country] => US [patent_app_date] => 2002-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 35676 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20030182672.pdf [firstpage_image] =>[orig_patent_app_number] => 10245805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7134574 [patent_doc_number] => 20040043386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Methods and compositions for functional ubiquitin assays' [patent_app_type] => new [patent_app_number] => 10/232951 [patent_app_country] => US [patent_app_date] => 2002-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 26307 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043386.pdf [firstpage_image] =>[orig_patent_app_number] => 10232951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 837134 [patent_doc_number] => 07393950 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-01 [patent_title] => 'Antisense oligonucleotides targeted to human CDC45' [patent_app_type] => utility [patent_app_number] => 10/232923 [patent_app_country] => US [patent_app_date] => 2002-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 12974 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/393/07393950.pdf [firstpage_image] =>[orig_patent_app_number] => 10232923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7208500 [patent_doc_number] => 20050053580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Use of microbiology non-viral substances for treating acne' [patent_app_type] => utility [patent_app_number] => 10/487618 [patent_app_country] => US [patent_app_date] => 2002-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5470 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20050053580.pdf [firstpage_image] =>[orig_patent_app_number] => 10487618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797076 [patent_doc_number] => 20030175950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'RNA interference mediated inhibition of HIV gene expression using short interfering RNA' [patent_app_type] => new [patent_app_number] => 10/225023 [patent_app_country] => US [patent_app_date] => 2002-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 38604 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175950.pdf [firstpage_image] =>[orig_patent_app_number] => 10225023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851529 [patent_doc_number] => 20030143732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'RNA interference mediated inhibition of adenosine A1 receptor (ADORA1) gene expression using short interfering RNA' [patent_app_type] => new [patent_app_number] => 10/224005 [patent_app_country] => US [patent_app_date] => 2002-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 35328 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143732.pdf [firstpage_image] =>[orig_patent_app_number] => 10224005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6829686 [patent_doc_number] => 20030180744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'High affinity oligonucleotide ligands to growth factors' [patent_app_type] => new [patent_app_number] => 10/223666 [patent_app_country] => US [patent_app_date] => 2002-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 32832 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180744.pdf [firstpage_image] =>[orig_patent_app_number] => 10223666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 326436 [patent_doc_number] => 07514207 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-07 [patent_title] => 'Methods of screening for compounds that decrease phosphorylation of merlin and may be useful in cancer treatment' [patent_app_type] => utility [patent_app_number] => 10/486750 [patent_app_country] => US [patent_app_date] => 2002-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 14 [patent_no_of_words] => 13585 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/514/07514207.pdf [firstpage_image] =>[orig_patent_app_number] => 10486750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 803193 [patent_doc_number] => 07422896 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-09-09 [patent_title] => 'Compositions for DNA mediated gene silencing' [patent_app_type] => utility [patent_app_number] => 10/217564 [patent_app_country] => US [patent_app_date] => 2002-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 26085 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 217 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/422/07422896.pdf [firstpage_image] =>[orig_patent_app_number] => 10217564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 733475 [patent_doc_number] => 07038036 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-02 [patent_title] => 'Oligonucleotides labeled with stable isotopes and a method for detecting the same' [patent_app_type] => utility [patent_app_number] => 10/214503 [patent_app_country] => US [patent_app_date] => 2002-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 4756 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 355 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/038/07038036.pdf [firstpage_image] =>[orig_patent_app_number] => 10214503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6652946 [patent_doc_number] => 20030008808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Antibacterial and antiviral agents and methods of screening for the same' [patent_app_type] => new [patent_app_number] => 10/212905 [patent_app_country] => US [patent_app_date] => 2002-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6721 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008808.pdf [firstpage_image] =>[orig_patent_app_number] => 10212905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7357863 [patent_doc_number] => 20040014049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Antisense modulation of protein kinase C-iota expression' [patent_app_type] => new [patent_app_number] => 10/199674 [patent_app_country] => US [patent_app_date] => 2002-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30710 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014049.pdf [firstpage_image] =>[orig_patent_app_number] => 10199674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7361833 [patent_doc_number] => 20040014699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Antisense modulation of PTPRM expression' [patent_app_type] => new [patent_app_number] => 10/200293 [patent_app_country] => US [patent_app_date] => 2002-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30365 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014699.pdf [firstpage_image] =>[orig_patent_app_number] => 10200293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6815132 [patent_doc_number] => 20030074682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Isolation, characterization, and use of a novel teleost potassium channel' [patent_app_type] => new [patent_app_number] => 10/193692 [patent_app_country] => US [patent_app_date] => 2002-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12737 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20030074682.pdf [firstpage_image] =>[orig_patent_app_number] => 10193692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725522 [patent_doc_number] => 20030207834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Oligonucleotide-containing pharmacological compositions and their use' [patent_app_type] => new [patent_app_number] => 10/191997 [patent_app_country] => US [patent_app_date] => 2002-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19318 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207834.pdf [firstpage_image] =>[orig_patent_app_number] => 10191997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6913182 [patent_doc_number] => 20050176940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Aptamers and antiaptamers' [patent_app_type] => utility [patent_app_number] => 10/482006 [patent_app_country] => US [patent_app_date] => 2002-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11726 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176940.pdf [firstpage_image] =>[orig_patent_app_number] => 10482006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6687933 [patent_doc_number] => 20030031658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Targeting of endosomal growth factor processing as anti-cancer therapy' [patent_app_type] => new [patent_app_number] => 10/170219 [patent_app_country] => US [patent_app_date] => 2002-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7178 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20030031658.pdf [firstpage_image] =>[orig_patent_app_number] => 10170219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6702376 [patent_doc_number] => 20030225256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Antisense modulation of pctaire protein kinase 2 expression' [patent_app_type] => new [patent_app_number] => 10/160787 [patent_app_country] => US [patent_app_date] => 2002-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30165 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20030225256.pdf [firstpage_image] =>[orig_patent_app_number] => 10160787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 390326 [patent_doc_number] => 07300922 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-27 [patent_title] => 'Modulators of pharmacological agents' [patent_app_type] => utility [patent_app_number] => 10/155233 [patent_app_country] => US [patent_app_date] => 2002-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 29 [patent_no_of_words] => 32461 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/300/07300922.pdf [firstpage_image] =>[orig_patent_app_number] => 10155233 [rel_patent_id] =>[rel_patent_doc_number] =>)